YZYan Zhang

Yan Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yan Zhang has a total of 75 co-authors. Here are the top co-authors by number of shared publications:

  • Hongbo Liu

    Renal, Electrolyte, and Hypertension Division, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America

    12 shared publications
  • Yanjun Wei

    College of Bioinformatics Science & Technology, Harbin Medical University, Harbin, 150086, PR China

    11 shared publications
  • Fang Wang

    College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China

    8 shared publications
  • Yihan Wang

    College of Bioinformatics Science and Technology, Harbin Medical University, China

    7 shared publications
  • Jianzhong Su

    College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China

    6 shared publications
  • Shumei Zhang

    College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China

    6 shared publications

Latest Publications

  • Integrated analysis of the prognostic role of the lymph node ratio in node-positive gastric cancer: A meta-analysis

    by Jiang Zhu, Zhao Xue, Shumei Zhang, Xinxin Guo, Laihui Zhai, Shipeng Shang, Yan Zhang, Haibo Lu

    The lymph node ratio (LNR) as a prognostic parameter for gastric cancer has yet to be fully validated in the current tumor node metastasis staging system. We assessed the prognostic role of LNR in lymph node-positive gastric cancer through a meta-analysis. PubMed and EMBASE were searched for relevant studies up until December 2016. The effect measure for meta-analysis of primary outcomes was the hazard ratio (HR) for overall survival. Pooled HRs and 95% confidence intervals were calculated using random effects models. The I2 statistic was used to measure heterogeneity. Subgroup analysis and meta-regression were chosen to illustrate the potential heterogeneity of the risk factors of outcomes. Publication bias was assessed using Egger's test and Begg's funnel plots. Sensitivity analysis was applied to evaluate the origin of the heterogeneity. We included 27 studies in this meta-analysis. Higher LNRs were significantly associated with a shorter overall survival (OS). High heterogeneity among the studies was identified (I2 = 85.6), and the publication bias was moderate. Subgroup analysis showed similar results, and elevated LNR was associated with late-stage gastric cancer and indicative of a worse prognosis. Univariate meta-regression analysis of OS indicated that both treatment type and ethnicity may be causes of heterogeneity in patients with gastric cancer (p values were 0.005 and 0.008, respectively). LNR was associated with a significantly poorer OS and LNR was an independent predictor of survival in patients with gastric cancer. LNR should be added as one of the parameters to be used in future tumor staging classification systems.


  • Exploration of Drug-Response Mechanism by Integrating Genetics and Epigenetics Across Cancers

    by Wenhua Lv, Mengying Zhang, Jiang Zhu, Min Zhang, Ce Ci, Shipeng Shang, Yanjun Wei, Hui Liu, Xin Li, Yan Zhang

    Aim: To discover CpG island methylator phenotype (CIMP) as a predictor for cancer drug-response mechanism. Materials & methods: CIMP classification of 966 cancer cell lines was determined according to identified copy number alteration and differential methylation by DNA methylation profiles. CIMP-related drugs were analyzed by analysis of variance. Tissue–cell–drug networks were developed to predict drug response of individual samples. Results & conclusion: One hundred and thirty-six copy number gain and 142 copy number loss cell lines were classified into CIMP-high and CIMP-low groups, meanwhile 9 and 24 CIMP-associated drugs were identified, respectively. Specially, breast invasive carcinoma samples primarily composed by HCC1419 were predicted to be sensitive to GSK690693. The study provides guidance for drug response in cancer therapy through genome-wide DNA methylation. Graphical abstract


  • Open Access

    Specific breast cancer prognosis‐subtype distinctions based onDNAmethylation patterns

    by Shumei Zhang, Yihan Wang, Yue Gu, Jiang Zhu, Ce Ci, Zhongfu Guo, Chuangeng Chen, Yanjun Wei, Wenhua Lv, Hongbo Liu, et al.

    Tumour heterogeneity is an obstacle to effective breast cancer diagnosis and therapy.DNAmethylation is an important regulator of gene expression, thus characterizing tumour heterogeneity by epigenetic features can be clinically informative. In this study, we explored specific prognosis‐subtypes based onDNAmethylation status using 669 breast cancers from theTCGAdatabase. Nine subgroups were distinguished by consensus clustering using 3869 CpGs that significantly influenced survival. The specificDNAmethylation patterns were reflected by different races, ages, tumour stages, receptor status, histological types, metastasis status and prognosis. Compared with thePAM50 subtypes, which use gene expression clustering,DNAmethylation subtypes were more elaborate and classified the Basal‐like subtype into two different prognosis‐subgroups. Additionally, 1252 CpGs (corresponding to 888 genes) were identified as specific hyper/hypomethylation sites for each specific subgroup. Finally, a prognosis model based on Bayesian network classification was constructed and used to classify the test set intoDNAmethylation subgroups, which corresponded to the classification results of the train set. These specific classifications byDNAmethylation can explain the heterogeneity of previous molecular subgroups in breast cancer and will help in the development of personalized treatments for the new specific subtypes.


  • Open Access

    The landscape of DNA methylation-mediated regulation of long non-coding RNAs in breast cancer

    by Chunlong Zhang, Xinyu Wang, Xuecang Li, Ning Zhao, Yihan Wang, Xiaole Han, Ce Ci, Jian Zhang, Meng Li, Yan Zhang

    // <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Chunlong Zhang1, *, Xinyu Wang2, *, Xuecang Li1, Ning Zhao3, Yihan Wang2, Xiaole Han1, Ce Ci2, Jian Zhang1, Meng Li1 and Yan Zhang2 1Department of Medical Informatics, Daqing Campus, Harbin Medical University, Daqing, 163000, China 2College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China 3School of Life Science and Technology, Harbin Institute of Technology, Harbin, 150081, China *These authors contributed equally to this work Correspondence to: Yan Zhang, email: tyozhang@ems.hrbmu.edu.cn Keywords: lncRNA, DNA methylation, network, breast cancer, hallmark Received: February 24, 2017 Accepted: April 24, 2017 Published: May 08, 2017 ABSTRACT Although systematic studies have identified a host of long non-coding RNAs (lncRNAs) which are involved in breast cancer, the knowledge about the methyla-tion-mediated dysregulation of those lncRNAs remains limited. Here, we integrated multi-omics data to analyze the methylated alteration of lncRNAs in breast invasive carcinoma (BRCA). We found that lncRNAs showed diverse methylation patterns on promoter regions in BRCA. LncRNAs were divided into two categories and four subcategories based on their promoter methylation patterns and expression levels be-tween tumor and normal samples. Through cis-regulatory analysis and gene ontology network, abnormally methylated lncRNAs were identified to be associated with can-cer regulation, proliferation or expression of transcription factors. Competing endog-enous RNA network and functional enrichment analysis of abnormally methylated lncRNAs showed that lncRNAs with different methylation patterns were involved in several hallmarks and KEGG pathways of cancers significantly. Finally, survival analysis based on mRNA modules in networks revealed that lncRNAs silenced by high methylation were associated with prognosis significantly in BRCA. This study enhances the understanding of aberrantly methylated patterns of lncRNAs and pro-vides a novel insight for identifying cancer biomarkers and potential therapeutic tar-gets in breast cancer.


  • Open Access

    Survival differences of CIMP subtypes integrated with CNA information in human breast cancer

    by Huihan Wang, Weili Yan, Shumei Zhang, Yue Gu, Yihan Wang, Yanjun Wei, Hongbo Liu, Fang Wang, Qiong Wu, Yan Zhang

    // <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Huihan Wang1, *, Weili Yan2, *, Shumei Zhang1, *, Yue Gu1, Yihan Wang1, Yanjun Wei1, Hongbo Liu1, Fang Wang1, Qiong Wu2 and Yan Zhang1 1College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China 2School of Life Science and Technology, State Key Laboratory of Urban Water Resource and Environment, Harbin Institute of Technology, Harbin, 150001, China *Joint first authors Correspondence to: Yan Zhang, email: tyozhang@ems.hrbmu.edu.cn Keywords: CpG island methylator phenotype (CIMP), breast cancer, copy number alteration (CNA), prognosis, biomarker Received: June 29, 2016 Accepted: March 01, 2017 Published: March 14, 2017 ABSTRACT CpG island methylator phenotype of breast cancer is associated with widespread aberrant methylation at specified CpG islands and distinct patient outcomes. However, the influence of copy number contributing to the prognosis of tumors with different CpG island methylator phenotypes is still unclear. We analyzed both genetic (copy number) and epigenetic alterations in 765 breast cancers from The Cancer Genome Atlas data portal and got a panel of 15 biomarkers for copy number and methylation status evaluation. The gene panel identified two groups corresponding to distinct copy number profiles. In status of mere-loss copy number, patients were faced with a greater risk if they presented a higher CpG islands methylation pattern in biomarker panels. But for samples presenting merely-gained copy number, higher methylation level of CpG islands was associated with improved viability. In all, the integration of copy number alteration and methylation information enhanced the classification power on prognosis. Moreover, we found the molecular subtypes of breast cancer presented different distributions in two CpG island methylation phenotypes. Generated by the same set of human methylation 450K data, additional copy number information could provide insights into survival prediction of cancers with less heterogeneity and might help to determine the biomarkers for diagnosis and treatment for breast cancer patients in a more personalized approach.


  • Open Access

    Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes

    by Juan Chen, Juan Xu, Yongsheng Li, Jinwen Zhang, Hong Chen, Jianping Lu, Zishan Wang, Xueying Zhao, Kang Xu, Yixue Li, et al.

    Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes


  • Open Access

    DiseaseMeth version 2.0: a major expansion and update of the human disease methylation database

    by Yichun Xiong, Yanjun Wei, Yue Gu, Shumei Zhang, Jie Lyu, Bin Zhang, Chuangeng Chen, Jiang Zhu, Yihan Wang, Hongbo Liu, et al.

    The human disease methylation database (DiseaseMeth, http://bioinfo.hrbmu.edu.cn/diseasemeth/) is an interactive database that aims to present the most complete collection and annotation of aberrant DNA methylation in human diseases, especially various cancers. Recently, the high-throughput microarray and sequencing technologies have promoted the production of methylome data that contain comprehensive knowledge of human diseases. In this DiseaseMeth update, we have increased the number of samples from 3610 to 32 701, the number of diseases from 72 to 88 and the disease-gene associations from 216 201 to 679 602. DiseaseMeth version 2.0 provides an expanded comprehensive list of disease-gene associations based on manual curation from experimental studies and computational identification from high-throughput methylome data. Besides the data expansion, we also updated the search engine and visualization tools. In particular, we enhanced the differential analysis tools, which now enable online automated identification of DNA methylation abnormalities in human disease in a case-control or disease-disease manner. To facilitate further mining of the disease methylome, three new web tools were developed for cluster analysis, functional annotation and survival analysis. DiseaseMeth version 2.0 should be a useful resource platform for further understanding the molecular mechanisms of human diseases.


  • Open Access

    The identification of age-associated cancer markers by an integrative analysis of dynamic DNA methylation changes

    by Yihan Wang, Jingyu Zhang, Xingjun Xiao, Hongbo Liu, Fang Wang, Song Li, Yanhua Wen, Yanjun Wei, Jianzhong Su, Yunming Zhang, et al.

    As one of the most widely studied epigenetic modifications, DNA methylation has an important influence on human traits and cancers. Dynamic variations in DNA methylation have been reported in malignant neoplasm and aging; however, the mechanisms remain poorly understood. By constructing an age-associated and cancer-related weighted network (ACWN) based on the correlation of the methylation level and the protein-protein interaction, we found that DNA methylation changes associated with age were closely related to the occurrence of cancer. Additional analysis of 102 module genes mined from the ACWN revealed discrimination based on two main patterns. One pattern involved methylation levels that increased with aging and were higher in cancer patients compared with normal controls (HH pattern). The other pattern involved methylation levels that decreased with aging and were lower in cancer compared with normal (LL pattern). Upon incorporation with gene expression levels, 25 genes were filtered based on negative regulation by DNA methylation. These genes were regarded as potential cancer risk markers that were influenced by age in the process of carcinogenesis. Our results will facilitate further studies regarding the impact of the epigenetic effects of aging on diseases and will aid in the development of tailored cancer preventive strategies.


  • Open Access

    NaCl stress-induced transcriptomics analysis of Salix linearistipularis (syn. Salix mongolica)

    by Guixian Nan, Yan Zhang, Song Li, Imshik Lee, Tetsuo Takano, Shenkui Liu

    Salix linearistipularis (syn. S. mongolica) is a woody halophyte, which is distributed naturally in saline-alkali soil of Songnen plain, Heilongjiang, China. It plays an important role in maintaining ecological balance and in improving saline soil. Furthermore, S. linearistipularis is also a genetic resource; however, there is no available information of genomic background for salt tolerance mechanism. We conducted the transcriptome analysis of S. linearistipularis to understand the mechanisms of salt tolerance by using RNA-seq technology. The transcription profiles of both the salt stress (SLH-treated) and the control (SLH-control) sample for S. linearistipularis were obtained by using RNA-seq in this study. By comparative analysis, only 3034 of 53,362 all-unigenes between two samples were expressed differently at more than 1.5-fold ( $$\left| {fold - change} \right| \ge 1.5$$ , FDR ≤ 0.05), including 1397 up-regulated genes and 1637 down-regulated genes. In total, 2199 genes were classified into 50 Gene Ontology (GO) terms and 1103 genes were involved in 116 biological pathways. To find salt stress related genes, all-unigenes of S. linearistipularis were classified into three categories according to their degree of the differentially expressed genes (DEGs) at 0–1.5-fold (non differently expressed genes, N-DEGs), at 1.5–4.0-fold and more than 4.0-fold. The pathways of three categorized genes were compared with the DEGs of Arabidopsis thaliana, showing that 22, 10 and 1 pathway of S. linearistipularis were overlapped with A. thaliana. Degree of the overlapping was categorized as 0–1.5-fold, 1.5–4.0-fold and more than 4.0-folds. Our study revealed that the N-DEGs of 22 pathways in S. linearistipularis were overlapped with the DEGs of A. thaliana. This result suggests that those overlapped genes that contrasted with the up- or down-regulated genes in A. thaliana were possibility evolved into housekeeping genes in S. linearistipularis under salt stress.


  • Open Access

    CellMethy: Identification of a focal concordantly methylated pattern of CpGs revealed wide differences between normal and cancer tissues

    by Fang Wang, Shaojun Zhang, Hongbo Liu, Yanjun Wei, Yihan Wang, Xiaole Han, Jianzhong Su, Dongwei Zhang, Baodong Xie, Yan Zhang

    DNA methylation patterns may serve as a key in determining cell phenotypes and functions. Adjacent CpG patterns may provide insight into methylation functional mechanisms. Some regions display different DNA methylation patterns between normal and cancer tissues, but the same average methylation level. Here, we developed a method (CellMethy) to infer a region in which all CpGs exhibit concordant methylation (CM) and to quantify the extent of CM in the region. Using simulation data, CellMethy showed high performance in discovering the concordant methylation patterns (AUC = 0.89). CellMethy was then applied to RRBS data including 11 normal tissues and 12 tumors. We found that the extent of CM exhibited wider differentials among tissues than did the average methylation levels from the CM regions, with 45% of CM regions occurring specifically in one tissue and mainly in tumors. Then, we identified CM regions through genome wide bisulfite sequencing (GWBS) data on breast cancer. Approximately 82% of CM regions revealed a significantly different extent of CM between cancer and normal tissues. CellMethy can accurately describe concordantly methylated regions, and the results suggest that CM might also serve as a stable marker of cell sub-populations.